Yeah. Thanks, Steve. So I think that 3.42% is sort of more of an anomaly for us given the originations that occurred. John, I think, highlighted in his remarks over $1 billion of loan originations, securities originations at the end of the quarter. So we'll get the full benefit of that as we get into the first quarter. And then if you add things like Ametros, and you just think of it like, mathematically, $800 million is coming in, at a minimum we're going to pay down FHLB borrowings that are 5.25% right. So you get the immediate benefit of that, and that'll carry out through the whole year. So that'll support our NIM. The other thing, and I know we've talked about this in the past, is we continue to have this dynamic, as I think all do, that fixed rate loans are repricing. So for us, it's like $1 billion, $1.2 billion in some quarters of fixed rate loans that are repricing. And to the extent they reprice into fixed rate loans, you're picking up 200 basis points. So that's added to NIM as well. The securities purchases, like we talked about, at the end of the quarter, you get the full year benefit of that. When you think about the restructuring we did on $400 million, we probably picked up about 400 basis points on that. These are all additive to NIM. And I think the dynamic here is that you'll see NIM supported in the first couple of quarters and it will carry out through the year. You will see -- we are asset-sensitive. So in the back half of the year, as the Fed starts to cut, you'll see NIM -- you'll see deposit costs begin to, which will initially be a lag, will begin to reprice down as well. So all that ins and outs, and there's a lot of moving pieces, as I'm sure you can appreciate. I would expect that the NIM would be in the range of 3.45% with some potential upside, depending on how the balance sheet rolls out.